AG
WST icon

Algert Global’s West Pharmaceutical WST Stock Holding History

Algert Global’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,140
Closed -$1.29M – 1425
2026
Q1 		$1.29M Buy
+5,140
New +$1.28M 0.02% 811
2024
Q1 		– Sell
-632
Closed -$223K – 1296
2023
Q4 		$223K Sell
632
-48
-7% -$17K 0.01% 1001
2023
Q3 		$255K Sell
680
-3,599
-84% -$1.39M 0.01% 918
2023
Q2 		$1.64M Sell
4,279
-32
-0.7% -$11.4K 0.07% 462
2023
Q1 		$1.49M Sell
4,311
-200
-4% -$58.4K 0.07% 457
2022
Q4 		$1.06M Buy
4,511
+298
+7% +$70.6K 0.06% 545
2022
Q3 		$1.04M Buy
4,213
+197
+5% +$60K 0.06% 526
2022
Q2 		$1.21M Buy
4,016
+853
+27% +$278K 0.09% 390
2022
Q1 		$1.3M Sell
3,163
-471
-13% -$184K 0.09% 401
2021
Q4 		$1.7M Buy
+3,634
New +$1.56M 0.21% 119
2021
Q1 		– Sell
-738
Closed -$209K – 545
2020
Q4 		$209K Hold
738
– – 0.06% 343
2020
Q3 		$203K Buy
+738
New +$195K 0.06% 313

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Algert Global's WST Position: Q2 2026 in Review

Algert Global sold out of West Pharmaceutical (WST) in Q2 2026, closing a stake of 5,140 shares — an estimated $1.29M sold.

Algert Global first reported a position in WST in Q3 2020 and held it in 12 quarters. The position peaked at $1.7M in Q4 2021. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Algert Global reported no remaining West Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Algert Global sold 5,140 West Pharmaceutical shares in Q2 2026, an estimated $1.29M.
  • Algert Global first reported a position in West Pharmaceutical in Q3 2020 and held it in 12 quarters.
  • Algert Global's West Pharmaceutical position peaked at $1.7M in Q4 2021.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.